1. Home
  2. TATT vs PRTA Comparison

TATT vs PRTA Comparison

Compare TATT & PRTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TAT Technologies Ltd.

TATT

TAT Technologies Ltd.

HOLD

Current Price

$52.19

Market Cap

505.2M

Sector

Industrials

ML Signal

HOLD

Logo Prothena Corporation plc

PRTA

Prothena Corporation plc

HOLD

Current Price

$9.38

Market Cap

495.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TATT
PRTA
Founded
1985
2012
Country
Israel
Ireland
Employees
N/A
N/A
Industry
Aerospace
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
505.2M
495.8M
IPO Year
1987
N/A

Fundamental Metrics

Financial Performance
Metric
TATT
PRTA
Price
$52.19
$9.38
Analyst Decision
Strong Buy
Buy
Analyst Count
5
9
Target Price
$48.40
$18.86
AVG Volume (30 Days)
184.5K
683.2K
Earning Date
11-12-2025
02-19-2026
Dividend Yield
N/A
N/A
EPS Growth
75.30
N/A
EPS
1.33
N/A
Revenue
$172,525,000.00
$11,786,000.00
Revenue This Year
$20.38
N/A
Revenue Next Year
$17.20
$1,183.79
P/E Ratio
$39.48
N/A
Revenue Growth
20.72
N/A
52 Week Low
$23.37
$4.32
52 Week High
$53.59
$16.67

Technical Indicators

Market Signals
Indicator
TATT
PRTA
Relative Strength Index (RSI) 71.83 48.04
Support Level $51.00 $8.65
Resistance Level $52.83 $9.34
Average True Range (ATR) 2.06 0.36
MACD 0.26 0.04
Stochastic Oscillator 86.12 69.71

Price Performance

Historical Comparison
TATT
PRTA

About TATT TAT Technologies Ltd.

TAT Technologies Ltd provides solutions and services to the commercial and military aerospace and ground defense industries, focused mainly on three product areas and services: Thermal Management, Power and Actuation, and Maintenance, Repair and Overhaul (MRO). Its product portfolio includes heat exchangers, cooling systems, and mechanical aircraft accessories and systems such as pumps, valves, and turbine power units. Its operating segments are MRO services for aviation components, which derive key revenue, Original equipment manufacturing (OEM) of heat transfer solutions and aviation accessories, MRO services for heat transfer components and OEM of heat transfer solutions, and Overhaul and coating of jet engine components. Geographically, it derives key revenue from the United States.

About PRTA Prothena Corporation plc

Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.

Share on Social Networks: